Hikma Pharmaceutical | HIK - Ebitda

Stock Price
1,384.50
Daily Change
-0.50 -0.04%
Monthly
10.14%
Yearly
-28.52%
Q2 Forecast
1,361.73

Hikma Pharmaceutical reported $369M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Almirall EUR 114.07M 60.37M Dec/2025
argenx SE USD 387.05M 99.02M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
Autolus Therapeutics Ltd USD -70.08M 11.23M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Orion EUR 130.4M 212.6M Mar/2026
Recordati EUR 247.15M 421K Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
UCB EUR 1.6B 570M Dec/2025